Programmed Death-Ligand 1 Expression in Lymphovascular Tumor Emboli in Lung Cancer

INTRODUCTION: Programmed death-ligand 1 (PD-L1) expression determined by immunohistochemistry is the most widely used biomarker for predicting response to immune checkpoint inhibitors. The characteristics of PD-L1 expression in tumor cells inside lymphovascular spaces are largely unknown. Although P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Yi-Chen, Ma, Hsiu-Hsun, Chu, Ping-Yuan, Ho, Hsiang-Ling, Chou, Teh-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250021/
https://www.ncbi.nlm.nih.gov/pubmed/35789791
http://dx.doi.org/10.1016/j.jtocrr.2022.100349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250021/
https://www.ncbi.nlm.nih.gov/pubmed/35789791
http://dx.doi.org/10.1016/j.jtocrr.2022.100349

Ejemplares similares